Salvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRI

Salvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRIПодробнее

Salvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRI

How Radiation Affects The Prostate | Mark Scholz, MDПодробнее

How Radiation Affects The Prostate | Mark Scholz, MD

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Lutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRIПодробнее

Lutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRI

Lutetium-177, Radiation For Urinary Flow, ProstRcision, & Ice For Chemo Side Effect | PCRI #12Подробнее

Lutetium-177, Radiation For Urinary Flow, ProstRcision, & Ice For Chemo Side Effect | PCRI #12

PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDПодробнее

PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MD

Treatment for Few Metastases | Oligo-Metastases Disease | Mark Scholz, MD | PCRIПодробнее

Treatment for Few Metastases | Oligo-Metastases Disease | Mark Scholz, MD | PCRI

Side Effects: Salvage Radiation, and Hormone Therapy | Mark Scholz, MD | PCRIПодробнее

Side Effects: Salvage Radiation, and Hormone Therapy | Mark Scholz, MD | PCRI

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRIПодробнее

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRI

Proton Therapy, IMRT, and SBRT | Mark Scholz, MD | PCRIПодробнее

Proton Therapy, IMRT, and SBRT | Mark Scholz, MD | PCRI

Lutetium-177, Diet, Prostatitis, and BPH | Answering YouTube Comments #1 | Mark Scholz, MDПодробнее

Lutetium-177, Diet, Prostatitis, and BPH | Answering YouTube Comments #1 | Mark Scholz, MD

Low Gleason Score (6 or 7) + High PSA? | Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

Low Gleason Score (6 or 7) + High PSA? | Prostate Cancer | Mark Scholz, MD | PCRI

Staging Prostate Cancer - MRI, PIRADS, & PSMA | Are Biopsies Still Needed? | Mark Scholz, MD | PCRIПодробнее

Staging Prostate Cancer - MRI, PIRADS, & PSMA | Are Biopsies Still Needed? | Mark Scholz, MD | PCRI

Using Lutetium-177 Treatment For Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDПодробнее

Using Lutetium-177 Treatment For Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRIПодробнее

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI

What Does Gleason 7 Mean? | Ask A Prostate Expert, Mark Scholz, MDПодробнее

What Does Gleason 7 Mean? | Ask A Prostate Expert, Mark Scholz, MD

Treatment Strategies for Gleason 3+4=7 vs. 4+3=7 | Ask a Prostate Cancer Expert, Mark Scholz, MDПодробнее

Treatment Strategies for Gleason 3+4=7 vs. 4+3=7 | Ask a Prostate Cancer Expert, Mark Scholz, MD

Gleason 4+3 = 7 #prostatecancer | First Steps | #markscholzmd | #pcriПодробнее

Gleason 4+3 = 7 #prostatecancer | First Steps | #markscholzmd | #pcri

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRI